In search for novel biomarkers of acute coronary syndrome.

Prerequisites for a biomarker to enter clinical routine in acute coronary syndrome (ACS) are several folds. The most important features are that the biomarker can be offered on a routine platform to diagnose and identify high-risk individuals of ACS, provide higher sensitivity and specificity than the ECG in predicting outcome, and should have impact on therapeutic decision making. In recent years, a deeper understanding of the pathobiology of the atherothrombosis as the underlying mechanism of ACS has directed scientific studies towards the evaluation of certain pathogenic components involved in the process as potential biomarkers for the clinical settings of ACS. Under investigations are markers to identify early injury/ischemia, markers for detection of vulnerable plaque, its disruption, of thrombosis and markers for inflammation. The aim of this paper is to review the current contribution of biochemical markers to clinical cardiology and also to discuss some important developments in this field.

• Publication year

  2012

• Venue

  Indian Heart Journal

• Publication date

  2012-04-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.5772/32129PMID 23550426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Traditional and Novel Risk Factors in Atherothrombosis

  2012cited by this paper
• A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.

  2011cited by this paper
• Study of C-Reactive Protein and Myocardial Infarction in the Indian Population

  2011cited by this paper
• The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications.

  2010cited by this paper
• Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes

  2010cited by this paper
• Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability

  2010cited by this paper
• Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes.

  2010influential reference
• Soluble levels of cell adhesion molecules (CAMs) in coronary artery disease.

  2010influential reference
• Circulating thrombotic and haemostatic components in patients with coronary artery disease

  2010cited by this paper
• Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.

  2010cited by this paper
• Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.

  2010cited by this paper
• The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction.

  2009cited by this paper
• Role of matrix metalloproteinases in coronary artery disease.

  2009influential reference
• BET 2. HEART FATTY ACID BINDING PROTEIN FOR RAPID DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN THE EMERGENCY DEPARTMENT

  2009influential reference
• Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease.

  2009cited by this paper
• Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.

  2008cited by this paper
• Circulating Stromelysin‐1 (MMP‐3): A novel predictor of LV dysfunction, remodelling and all‐cause mortality after acute myocardial infarction

  2008cited by this paper
• Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.

  2008cited by this paper
• Ischaemia-modified albumin: clinical utility and pitfalls in measurement

  2008cited by this paper
• Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome.

  2008cited by this paper
• Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI, CK-MB and myoglobin

  2008cited by this paper
• [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].

  2007cited by this paper
• Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome

  2007cited by this paper
• Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.

  2007cited by this paper
• Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.

  2007cited by this paper
• Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study

  2007cited by this paper
• The cut-off point of interleukin-6 level in acute coronary syndrome.

  2007cited by this paper
• National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.

  2007cited by this paper
• [Measurement peripheral blood index related to inflammation and ox-LDL, ox-LDLAb in patients with coronary heart disease and its clinical significance].

  2006cited by this paper
• Influence of sample type and storage conditions on soluble CD40 ligand assessment.

  2006cited by this paper
• Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells.

  2006cited by this paper
• Increased serum cathepsin S in patients with atherosclerosis and diabetes.

  2006cited by this paper
• Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults

  2005cited by this paper
• Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome.

  2005cited by this paper
• Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.

  2005cited by this paper
• Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis

  2005cited by this paper
• Cystatin-C and mortality in elderly persons with heart failure.

  2005cited by this paper
• Quest for novel cardiovascular biomarkers by proteomic analysis.

  2005cited by this paper
• Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.

  2005cited by this paper
• Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

  2004cited by this paper
• Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non–ST-Elevation Acute Coronary Syndrome

  2004cited by this paper
• A superior early myocardial infarction marker

  2004cited by this paper
• Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis.

  2004cited by this paper
• Using C-reactive protein to assess cardiovascular disease risk.

  2003cited by this paper
• Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations.

  2003cited by this paper
• Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy.

  2003cited by this paper
• C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis

  2003cited by this paper
• Prognostic implications of elevated whole blood choline levels in acute coronary syndromes.

  2003cited by this paper
• New Markers of Inflammation and Endothelial Cell Activation: Part I

  2003cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome.

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation

  2003cited by this paper
• Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes

  2003cited by this paper
• [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].

  2003cited by this paper
• Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2002cited by this paper
• Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase

  2002cited by this paper
• Serum levels of unbound free fatty acids reveal high sensitivity for early detection of acute myocardial infarction in patient samples from the TIMI II trial

  2002cited by this paper
• Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes.

  2002cited by this paper
• Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application?

  2002cited by this paper
• Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice.

  2002cited by this paper
• Acute coronary syndrome: biochemical strategies in the troponin era.

  2002influential reference
• T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes

  2002cited by this paper
• A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis

  2002cited by this paper
• New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.

  2002cited by this paper
• Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes.

  2001cited by this paper
• Acute coronary syndrome without ST elevation: implementation of new guidelines.

  2001cited by this paper
• Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

  2001cited by this paper
• Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia.

  2001cited by this paper
• Association between myeloperoxidase levels and risk of coronary artery disease.

  2001cited by this paper
• The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

  2001cited by this paper
• Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty

  2001cited by this paper
• Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.

  2001influential reference
• Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.

  2001cited by this paper
• Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.

  2000cited by this paper
• The insulin-like growth factor axis: A review of atherosclerosis and restenosis.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL.

  2000cited by this paper
• Interferon-γ and Lipopolysaccharide Potentiate Monocyte Tissue Factor Induction by C-Reactive Protein Relationship With Age, Sex, and Hormone Replacement treatment

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• PECAM-1 (CD31) expression modulates bleeding time in vivo.

  2000cited by this paper
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.

  2000cited by this paper
• A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report.

  2000cited by this paper
• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

  2000cited by this paper
• Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment.

  2000cited by this paper
• Soluble PECAM-1, but Not P-Selectin, Nor Osteonectin Identify Acute Myocardial Infarction in Patients Presenting with Chest Pain

  1999cited by this paper
• Cellular adhesion molecules on vascular smooth muscle cells.

  1999cited by this paper
• Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction.

  1999cited by this paper
• Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study.

  1999cited by this paper
• Circulating Levels of Secretory Type II Phospholipase A2 Predict Coronary Events in Patients with Coronary Artery Disease

  1999cited by this paper
• Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage.

  1998cited by this paper
• Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes.

  1998cited by this paper
• C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction.

  1997cited by this paper
• Molecular mechanism of cellular uptake and intracellular translocation of fatty acids.

  1997cited by this paper
• Increased plasma tissue factor levels in acute myocardial infarction.

  1997cited by this paper

• No citing papers are available for this paper.